| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7908f36ceaf69c2f7dee58ac58b8baf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_711fbbce79f861f7be084f759083a60a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5020d6460dc54a87f0cf98bc770fc67 |
| publicationDate |
2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019059673-A |
| titleOfInvention |
Therapeutic agent for PBC |
| abstract |
PROBLEM TO BE SOLVED: To provide a novel therapeutic agent useful for the treatment of PBC. [Solution means] The present invention provides a therapeutically effective amount of (R) -2- [3-[[N- (benzoxazol-2-yl) -N-3- (4-methoxyphenoxy) propyl] aminomethyl] phenoxy] butyric acid The present invention relates to a pharmaceutical composition for treating primary biliary cirrhosis (PBC), including its salts, or their solvates. 【Selection chart】 None |
| priorityDate |
2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |